Ilhan Lim

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Advanced Non Small Cell Lung Cancer

Metastatic Breast Cancer

Positron Emission Tomography

Top Venues

EJNMMI research

Annals of nuclear medicine

European journal of nuclear medicine and molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Inki Lee, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Kyo Chul Lee, Choong Mo Kang, Min-Ki Seong, Hyun-Ah Kim, Woo Chul Noh, Sang Moo Lim
The Prediction of HER2-Targeted Treatment Response Using 64 Cu-Tetra-Azacyclododecanetetra-Acetic Acid (DOTA)-Trastuzumab PET/CT in Metastatic Breast Cancer: A Case Report. Journal of breast cancer 25 (1) (2022)
Joon Ho Choi, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Hye Jin Kang, Dong-Yeop Shin, Sang Moo Lim
The role of 18F-FDG PET/CT in patients with diffuse large B-cell lymphoma after radioimmunotherapy using 131I-rituximab as consolidation therapy. PloS one 17 (9) (2022)
Chul-Hee Lee, Ilhan Lim, Sang-Keun Woo, Wook Kim, Kwang Il Kim, Kyo Chul Lee, Kanghyon Song, Sang Moo Lim
Targeted alpha immunotherapy of CD20-positive B-cell lymphoma model: dosimetry estimate of 225Ac-DOTA-rituximab using 64Cu-DOTA-rituximab. Annals of nuclear medicine 35 (5) (2021)
Inki Lee, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang-Keun Woo, Kwang Il Kim, Kyo Chul Lee, Joo Hyun Kang, Min-Ki Seong, Hyun-Ah Kim, Woo Chul Noh, Sang Moo Lim
A preliminary clinical trial to evaluate 64Cu-NOTA-Trastuzumab as a positron emission tomography imaging agent in patients with breast cancer. EJNMMI research 11 (1) (2021)
Inki Lee, Ilhan Lim, Byung Hyun Byun, Byung Il Kim, Chang Woon Choi, Sang-Keun Woo, Kyo Chul Lee, Joo Hyun Kang, Hee Seup Kil, Chansoo Park, Dae Yoon Chi, Jongwook Park, Kanghyon Song, Sang Moo Lim
A microdose clinical trial to evaluate [18F]Florastamin as a positron emission tomography imaging agent in patients with prostate cancer. European journal of nuclear medicine and molecular imaging 48 (1) (2020)